New England Biolabs (NEB), a world leader in the production and supply of reagents for the life science industry, has licensed the ERGO™ bioinformatics software developed and maintained by Integrated Genomics. NEB will utilize the ERGO™ genome analysis tools for gene annotation, metabolic reconstruction and enzyme data-mining as well as for comparative genomics purposes.
“The ERGO™ platform gives us a valuable and comprehensive resource for our genomics studies and provides a powerful data-mining environment for our scientists” said Dr Barton Slatko, Senior Scientist in the Molecular Parasitology Division at NEB.
Optimized for analysis of microorganisms, ERGO™ integrates biological data from genomics, biochemistry, gene expression studies, genetics and literature. Reaching beyond conventional systems for functional analysis by DNA sequence alone, Integrated Genomics' platform combines pattern-based analyses with a repertoire of comparative genomics tools for gene visualization in the contexts of regulation, expression data, phylogeny, chromosomal neighborhoods and gene fusions. ERGO™ contains more than 1180 genomes at various stages of completion, as well as the largest available collection of networked cellular pathways.
About Integrated Genomics
Integrated Genomics is a provider of bioinformatics products and services for the life sciences industry. The company’s expertise in microbial genomics includes genome sequencing, comparative genomics and custom bioinformatics applications. IG has developed and distributes ERGO™, the most advanced and comprehensive bioinformatics suite for microbial genomics on the market. ERGO™ contains the largest available integration of microbial genome data, including genome-derived metabolic reconstructions representing over 6,000 networked metabolic and non-metabolic pathways.
About New England Biolabs
New England Biolabs leads the industry in the discovery and production of enzymes for life science applications. Established in the mid-1970s, NEB now offers the largest selection of recombinant and native enzymes for DNA work, genomics and proteomics. New England Biolabs also supplies protein expression systems, competent cells and transfection reagents. New England Biolabs is a privately held company headquartered in Ipswich, MA and has extensive worldwide distribution through a network of exclusive distributors, agents and five subsidiaries located in Canada, China, Germany, Japan and the UK.